Is it possible to train the body to resist seasonal allergies? That’s the hope promised by a new line of immunotherapy reviving an old treatment.

The patent expiry on the global blockbuster drug could reshape obesity and diabetes care, but raises fresh questions on safety, access and regulation.

A massive, self-replicating GlassWorm supply-chain attack has compromised hundreds of code repositories and extensions on GitHub, npm, and Open VSX.

TTV Capital has been a quiet force in the fintech world for a while now. They’re not the flashiest firm out there, but they seem to have a knack for picking companies that end up making a real ...

Tech stocks were a drag on the market Thursday as Nvidia’s solid fourth-quarter earnings failed to sustain a recent rebound in shares of technology companies.

A nationwide blackout has added new challenges for Cuba’s government after its power grid collapsed. Vegas Stronger ramps up ...